Guggenheim Capital LLC Tg Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$13.3 Billion
Q3 2025

A detailed history of Guggenheim Capital LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 38,748 shares of TGTX stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,748

Previous 36,420 6.39%

Holding current value

$1.2 Million

Previous $1.31 Million 6.79%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$26.39 - $39.19 $61,435 - $91,234	2,328 Added 6.39%	38,748 $1.4 Million
Q2 2025 Aug 13, 2025	BUY	$33.37 - $45.51 $17,052 - $23,255	511 Added 1.42%	36,420 $1.31 Million
Q1 2025 May 14, 2025	SELL	$27.67 - $42.99 $153,623 - $238,680	-5,552 Reduced 13.39%	35,909 $1.42 Million
Q4 2024 Feb 13, 2025	SELL	$21.31 - $35.09 $317,625 - $523,016	-14,905 Reduced 26.44%	41,461 $1.25 Million
Q3 2024 Nov 13, 2024	SELL	$17.21 - $25.28 $30,564 - $44,897	-1,776 Reduced 3.05%	56,366 $1.32 Million

Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $40,652 - $58,567	-3,052 Reduced 4.99%	58,142 $1.03 Million
Q1 2024 May 14, 2024	BUY	$13.02 - $21.3 $31,859 - $52,121	2,447 Added 4.17%	61,194 $930,000
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $132,297 - $372,532	-19,805 Reduced 25.21%	58,747 $1 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $253,884 - $804,778	30,369 Added 63.03%	78,552 $656,000
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $331,318 - $749,105	-21,403 Reduced 30.76%	48,183 $1.2 Million
Q1 2023 May 10, 2023	BUY	$10.23 - $19.34 $711,864 - $1.35 Million	69,586 New	69,586 $1.05 Million
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $417,589 - $1.19 Million	-111,655 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $188,033 - $492,354	24,076 Added 27.49%	111,655 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $354,707 - $828,661	23,336 Added 36.32%	87,579 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $144,248 - $267,900	6,623 Added 11.49%	64,243 $2.14 Million
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $181,480 - $273,392	5,584 Added 10.73%	57,620 $2.24 Million
Q1 2021 May 13, 2021	BUY	$41.61 - $54.3 $2.17 Million - $2.83 Million	52,036 New	52,036 $2.51 Million
Q2 2018 Aug 14, 2018	SELL	$12.5 - $15.0 $937,175 - $1.12 Million	-74,974 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $664,793 - $1.28 Million	-76,413 Reduced 50.48%	74,974 $1.06 Million
Q4 2017 Feb 14, 2018	BUY	$7.35 - $12.3 $363,472 - $608,259	49,452 Added 48.51%	151,387 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$10.0 - $12.7 $1.02 Million - $1.29 Million	101,935	101,935 $1.21 Million

Others Institutions Holding TGTX

# of Institutions

395

Shares Held

90.5M

Call Options Held

1.77M

Put Options Held

1.9M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Tg Therapeutics, Inc. Transaction History